arrow_back Civic Audit
Share share

Digital Drug Information: Ending Mandatory Paper Inserts for Healthcare Providers

This law changes how drug manufacturers provide prescribing and safety information to healthcare professionals. The default format will shift from mandatory paper inserts to digital communication, aiming to modernize the system and ensure faster access to updated data. Crucially, doctors and pharmacists retain the right to request and receive paper copies free of charge whenever needed.
Key points
Drug prescribing information (dosing, warnings) will primarily be provided digitally to doctors and pharmacies.
Manufacturers must still offer healthcare providers the option to request and receive paper copies free of charge upon demand.
The goal is to speed up drug data updates and reduce paper usage within the healthcare system.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Introduced
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Print number: 119_HR_4132
Sponsor: Rep. Harshbarger, Diana [R-TN-1]
Process start date: 2025-06-25
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-flash-latest
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Prescription Information Modernization Act of 2025

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_HR_4132.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2025-06-25.

What are the main provisions?

Key points include:

  • Drug prescribing information (dosing, warnings) will primarily be provided digitally to doctors and pharmacies.
  • Manufacturers must still offer healthcare providers the option to request and receive paper copies free of charge upon demand.
  • The goal is to speed up drug data updates and reduce paper usage within the healthcare system.
What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Harshbarger, Diana [R-TN-1].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Energy and Commerce.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-31.

What is the impact of this bill?

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge.

CATEGORIES

Health Informatization